(Q37406915)

20 August 2017

1 reference

title

Overutilization of proton pump inhibitors: a review of cost-effectiveness and risk [corrected]. (English)

1 reference

cost-effectiveness analysis

20 August 2017

main subject

1 reference

3

John M Inadomi

1 reference

20 August 2017

Joel J Heidelbaugh

1

1 reference

20 August 2017

Kathleen L Goldberg

series ordinal

2

1 reference

20 August 2017

language of work or name

English

0 references

publication date

1 March 2009

1 reference

The American Journal of Gastroenterology

20 August 2017

published in

1 reference

20 August 2017

volume

104 Suppl 2

1 reference

20 August 2017

page(s)

S27-32

1 reference

Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease

20 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.49

Why are patients prescribed proton pump inhibitors? Retrospective analysis of link between morbidity and prescribing in the General Practice Research Database

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.49

Tetany secondary to the use of a proton-pump inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.49

Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.49

Long-term treatment with omeprazole for refractory reflux esophagitis: efficacy and safety.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FAJG.2009.49

21 January 2018

Identifiers

DOI

10.1038/AJG.2009.49

1 reference

20 August 2017

1 reference